THERANOSTICS 2016* Feng Wang
Nanjing First Hospital,Nanjing Medical university, JIANGSU, China
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
RGD imaging serve as a surrogate for molecular phenotyping and prognosis: A Prospective Study of 99mTc-3PRGD2 SPECT/CT in 226 Patients with Suspected Lung Cancer (#128)
8:30 AM
Feng Wang
Conference Breakfast: Moderated Poster Walk - Novel Theranostics
The Role of 99mTc-galacto-RGD2 SPECT/CT in the Clinical Management of Refractory Thyroid Cancer (#129)
8:30 AM
Feng Wang
Conference Breakfast: Moderated Poster Walk - Novel Theranostics
99mTc-MIBI Dual-phase Imaging with Hybrid SPECT/CT for the Diagnosis of Rare Parathyroid Carcinoma (#53)
8:30 AM
zejun chen
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours
68Ga-PSMA-11 PET/CT for the Staging and Risk Stratification of Chinese men with Prostate cancer (#75)
8:30 AM
Feng Wang
Conference Breakfast: Moderated Poster Walk - Prostate tumours
Serum Chromogranin A in the Screening and Diagnosis of GEP-NENs (#54)
8:30 AM
Feng Wang
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours